{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T11:23:18Z","timestamp":1698664998682},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.mehy.2007.04.027","type":"journal-article","created":{"date-parts":[[2007,6,20]],"date-time":"2007-06-20T11:19:19Z","timestamp":1182338359000},"page":"81-84","source":"Crossref","is-referenced-by-count":4,"title":["Topical morphine for the treatment of cutaneous leishmaniasis"],"prefix":"10.1016","volume":"70","author":[{"given":"Roya","family":"Alavi-Naini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2007.04.027_bib1","series-title":"Tropical diseases research progress","first-page":"77","article-title":"Leishmainiasis","author":"Modabber","year":"1995"},{"key":"10.1016\/j.mehy.2007.04.027_bib2","unstructured":"Thirteenth Program Report: Special program for research and training in tropical diseases, Leishmaniasis. Geneva: World Health Organization; 1997. p. 100\u201311."},{"key":"10.1016\/j.mehy.2007.04.027_bib3","series-title":"The leishmaniasis in biology and medicine","article-title":"Morphology, ultrastructure and life cycles","volume":"vol. 1","author":"Molyneux","year":"1987"},{"key":"10.1016\/j.mehy.2007.04.027_bib4","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2230.2006.02182.x","article-title":"Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial","volume":"31","author":"Asilian","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.mehy.2007.04.027_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/136485905X16372","article-title":"Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran","volume":"99","author":"Iraji","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"key":"10.1016\/j.mehy.2007.04.027_bib6","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1128\/AAC.42.12.3092","article-title":"Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B","volume":"42","author":"Frankenburg","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mehy.2007.04.027_bib7","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/01.inf.0000069794.83612.2f","article-title":"Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B","volume":"22","author":"Zvulunov","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.mehy.2007.04.027_bib8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1086\/314782","article-title":"Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S-28463: efficacy and mode of action","volume":"179","author":"Buates","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mehy.2007.04.027_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0035-9203(99)90192-X","article-title":"Topical treatment with hexadecylphosphocholine (Miltex) efficiently reduces parasite burden in experimental cutaneous leishmaniasis","volume":"93","author":"Schmidt-Ott","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.mehy.2007.04.027_bib10","doi-asserted-by":"crossref","first-page":"147","DOI":"10.4269\/ajtmh.2002.66.147","article-title":"Treatment of cutaneous leishmaniasis with a topical antileishmanial drug (WR279396): phase 2 pilot study","volume":"66","author":"Soto","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.mehy.2007.04.027_bib11","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1211\/jpp.58.8.0004","article-title":"In-vitro and in-vivo studies on a topical formulation of sitamaquine dihydrochloride for cutaneous leishmaniasis","volume":"58","author":"Garnier","year":"2006","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mehy.2007.04.027_bib12","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1211\/jpp.59.1.0006","article-title":"Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis","volume":"59","author":"Garnier","year":"2007","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.mehy.2007.04.027_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740338.4.4.669","article-title":"Immunomodulatory effect of morphine: therapeutic implications","volume":"4","author":"Dinda","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.mehy.2007.04.027_bib14","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1128\/IAI.69.5.3232-3239.2001","article-title":"Flow cytometric determination of cellular sources and frequencies of key cytokine-producing lymphocytes directed against recombinant LACK and soluble Leishmania antigen in human cutaneous leishmaniasis","volume":"69","author":"Bottrel","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2007.04.027_bib15","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/IAI.70.6.3122-3129.2002","article-title":"LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection","volume":"70","author":"Bourreau","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2007.04.027_bib16","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1128\/IAI.71.5.2674-2683.2003","article-title":"The levels and patterns of cytokines produced by CD4 T lymphocytes of BALB\/c mice infected with Leishmania major by inoculation into the ear dermis depend on the infectiousness and size of the inoculum","volume":"71","author":"Lang","year":"2003","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2007.04.027_bib17","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1128\/IAI.66.6.2698-2704.1998","article-title":"Indications of the protective role of natural killer cells in human cutaneous leishmaniasis in an area of endemicity","volume":"66","author":"Maasho","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.mehy.2007.04.027_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0165-5728(97)00222-1","article-title":"The opioid-cytokine connection","volume":"83","author":"Peterson","year":"1998","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.mehy.2007.04.027_bib19","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0090-1229(83)90074-0","article-title":"Opiate receptors on lymphocytes and platelets in man","volume":"27","author":"Mehrishi","year":"1983","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.mehy.2007.04.027_bib20","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/0006-2952(80)90431-1","article-title":"Stereoselective muscarinic acetylcholine and opiate receptiors in human phagocytic leukocytes","volume":"29","author":"Lopker","year":"1980","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2007.04.027_bib21","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.4049\/jimmunol.132.6.3046","article-title":"Beta-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis","volume":"132","author":"van Epps","year":"1984","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2007.04.027_bib22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.4049\/jimmunol.154.3.1323","article-title":"Human granulocytes contain an opiate alkaloid-selective receptor mediating inhibition of cytokine-induced activation and chemotaxis","volume":"154","author":"Makman","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2007.04.027_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1084\/jem.188.2.317","article-title":"Opiates transdeactivate chemokine receptors: delta and mu opiate receptor-mediated heterologous desensitization","volume":"188","author":"Grimm","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2007.04.027_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0376-8716(00)00181-2","article-title":"Opioids, opioid receptors, and the immune response","volume":"62","author":"McCarthy","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.mehy.2007.04.027_bib25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0008-8749(86)90064-X","article-title":"Opioid peptides modulate production of interferon gamma by human mononuclear cells","volume":"103","author":"Brown","year":"1986","journal-title":"Cell Immunol"},{"key":"10.1016\/j.mehy.2007.04.027_bib26","doi-asserted-by":"crossref","first-page":"934","DOI":"10.4049\/jimmunol.136.3.934","article-title":"beta-Endorphin augments the cytolytic activity and interferon production of natural killer cells","volume":"136","author":"Mandler","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2007.04.027_bib27","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1006\/bbrc.1998.8415","article-title":"Morphine modulates NF kappa B activation in macrophages","volume":"245","author":"Roy","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2007.04.027_bib28","doi-asserted-by":"crossref","first-page":"5431","DOI":"10.4049\/jimmunol.159.11.5431","article-title":"Delta-opioid receptors expressed by Jurkat T cells enhance IL-2 secretion by increasing AP-1 complexes and activity of the NF-AT\/AP-1-binding promoter element","volume":"159","author":"Hedin","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2007.04.027_bib29","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000069970","article-title":"Neuroimmunomodulatory effects of morphine in Leishmania donovani-infected hamsters","volume":"10","author":"Singal","year":"2002","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.mehy.2007.04.027_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.micinf.2004.10.005","article-title":"Leishmania donovani amastigote component-induced colony-stimulating factor production by macrophages: modulation by morphine","volume":"7","author":"Singal","year":"2005","journal-title":"Microbes Infect"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987707003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T12:36:19Z","timestamp":1683894979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987707003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0306987707003118"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2007.04.027","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]}}}